Matinas BioPharma Holdings, Inc. Share Price
Equities
MTNB
US5768101058
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1789 USD | -1.43% | -4.69% | -17.25% |
27/03 | Transcript : Matinas BioPharma Holdings, Inc., 2023 Earnings Call, Mar 27, 2024 | |
27/03 | Matinas BioPharma Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 44.87M 3.74B |
---|---|---|---|---|---|
Net income 2024 * | -28M -2.33B | Net income 2025 * | -29M -2.42B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.49
x | P/E ratio 2025 * |
-1.79
x | Employees | 32 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.47% |
Latest transcript on Matinas BioPharma Holdings, Inc.
1 day | -1.43% | ||
1 week | -4.69% | ||
Current month | -33.99% | ||
1 month | -37.38% | ||
3 months | -8.77% | ||
6 months | -14.40% | ||
Current year | -17.25% |
Managers | Title | Age | Since |
---|---|---|---|
Jerome Jabbour
FOU | Founder | 50 | 01/13/01 |
Keith Kucinski
DFI | Director of Finance/CFO | 55 | 03/19/03 |
Hui Liu
CTO | Chief Tech/Sci/R&D Officer | 56 | 01/20/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Herbert Conrad
FOU | Founder | 91 | 01/13/01 |
Natasha Giordano
BRD | Director/Board Member | 62 | 14/20/14 |
Eric Ende
CHM | Chairman | 55 | 03/17/03 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 0.1789 | -1.43% | 1,479,335 |
25/24/25 | 0.1815 | -0.17% | 683,401 |
24/24/24 | 0.1818 | +0.17% | 521,887 |
23/24/23 | 0.1815 | +0.83% | 767,399 |
22/24/22 | 0.18 | -4.10% | 1,378,937 |
Delayed Quote Nyse, April 27, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.25% | 44.87M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- MTNB Stock